Breast cancer management in middle-resource countries (MRCs): Consensus statement from the Breast Health Global Initiative

Yip, Cheng Har; Cazap, Eduardo; Anderson, Benjamin O.; Bright, Kristin; Caleffi, Maira; Cardoso, Fátima; Elzawawy, Ahmed; Harford, Joe B.; Krygier, Gabriel; Masood, Shahla; Murillo, Raúl; Musé, Ignacio; Otero, Isabel V.; Passman, Leigh J.; Santini, Luiz Antônio; Silva, Ronaldo Corrêa Ferreira da; Thomas, David B.; Torres, Soledad; Zheng, Ying; Khaled, Hussein

doi:10.1016/j.breast.2011.02.015

Cited by 56 publications

(62 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…"s it is the case in many other low-and middle-income countries, there is no institutional public program available in Mexico that provides free coverage for rehabilitation services to "C women after surgery [55]. "t present, the health system mainly focuses on survival, namely, on primary and adjuvant treatment [56,57] whereby postreatment care is left to NGOs such as the RETO group that provide information, exercise programs, lymphatic drainage and other activities to support women during the rehabilitation period. Yet, this study and others [16,17,39,40] illustrate the need of rehabilitation and psychological therapy in addition to surgical treatment and radiotherapy for "C women.…”

Section: Discussionmentioning

confidence: 99%

“…Diferential accessibility to health services has been acknowledged in Mexico by health authorities who have even called for strong patients' advocacy groups to improve cancer care [58]. Unfortunately, the notion that survival is the main and almost only goal of treatment seems to prevail among both, patients and health personnel and so far litle atention is being paid to the provision of beter care after "C surgery [57].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Felt Needs for Rehabilitation After Breast Cancer Treatment in Mexico

Hammelin¹,

Tejada-Tayabas²,

Galarza‐Tejada³

et al. 2017

Breast Cancer - From Biology to Medicine

View full text Add to dashboard Cite

Abstract"reast cancer "C is the most frequent type of malignancy among women worldwide and the most common cause of mortality, particularly in low and middle-income countries. "s detection and treatment have improved, a larger number of surviving women need adequate rehabilitation after treatment. However, awareness among afected patients remains low. Thus, the aim of this study was to explore the needs and expectations concerning rehabilitation among Mexican women after breast surgery. "n ethnographic approach was used. Eight focus groups were conducted in the north-central state of San Luis Potosí, Mexico, in 2014, in which women under treatment and survivors participated. Results showed that women had insuicient and misleading information concerning the need for rehabilitation from health care authorities. Women seemed to focus more on survival than on quality of life after treatment even though impairments limiting their daily life activities caused frustration and feelings of uselessness. In conclusion, many women perceived the need for rehabilitation, but information was largely lacking. Public health services fail to provide rehabilitation services, which are now partially covered by private organizations. Treatment for breast cancer should be accompanied by rehabilitation. "wareness, availability and access to physiotherapy services need to be put in place.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Felt Needs for Rehabilitation After Breast Cancer Treatment in Mexico

Hammelin¹,

Tejada-Tayabas²,

Galarza‐Tejada³

et al. 2017

Breast Cancer - From Biology to Medicine

View full text Add to dashboard Cite

show abstract

“…The local practice setting, including resource constraints, has to be heeded when considering implementation of systemic therapy recommendations. Guidelines by groups such as the Breast Health Global Initiative [81][82][83] could help users of this guideline to better choose the most resource-appropriate systemic therapies for their unique practice setting.…”

Section: Methodsmentioning

confidence: 99%

Optimal Systemic Therapy for Early Breast Cancer in Women: A Clinical Practice Guideline

et al. 2015

View full text Add to dashboard Cite

The Breast Cancer Disease Site Group of Cancer Care Ontario identified the need for new guidelines for the adjuvant systemic therapy of early-stage breast cancer. The specific question to be addressed was “What is the optimal adjuvant systemic therapy for female patients with early-stage operable breast cancer, when patient and disease factors are considered?”A systematic review was prepared based on literature searches conducted using the medline and embase databases for the period January 2008 to March 5, 2012, and updated to May 12, 2014. Guidelines were located from that search, from the Standards and Guidelines Evidence directory of cancer guidelines, and from the Web sites of major guideline organizations. The literature located was subdivided into the broad categories of chemotherapy, hormonal therapy, and therapy targeted to her2 (human epidermal growth factor receptor 2). Although several of the systemic therapies discussed in this guideline can be considered in the neoadjuvant setting, the review focused on trials with rates of disease-free and overall survival as endpoints and thus excluded several trials that used pathologic complete response as a primary endpoint.Based on the systematic review, the working group drafted recommendations on the use of chemotherapy, hormonal therapy, and targeted therapy; based on their professional experience, they also drafted recommendations on patient and disease characteristics and recurrence risk. The literature review and draft recommendations were circulated to a consensus panel of medical oncologists who had expertise in breast cancer and who represented the regions of Ontario. Items without initial consensus were discussed at an in-person consensus meeting held in Toronto, November 23, 2012. The final recommendations are those for which consensus was reached before or at the meeting. Some of the key evidence was revised after the updated literature search. Evidence reviews for systemic chemotherapy, endocrine therapy, and targeted therapy for her2-positive disease are reported in separate articles in this supplement. The full three-part 1-21 evidence-based series, including complete details of the development and consensus processes, can be found on the Cancer Care Ontario Web site at https://www.cancercare.on.ca/toolbox/qualityguidelines/diseasesite/breast-ebs.

show abstract

“…The goal of earlier detection in low-resource regions is to treat the disease on time so as to prevent it from spreading. This goal can be achieved by reinforcing the importance of seeking timely examinations and treatments [26][27][28][29][30] . Diagnosis of breast cancer in the earlier stages of the disease has been positively associated with a decrease in breast cancer mortality and improved prognosis 10 .…”

Section: The Importance Of Early Detection and Diagnosis Of Breast Camentioning

confidence: 99%

COMMENTARY: Promoting Early Detection of Breast Cancer and Care Strategies for Nigeria

Ogunkorode

Holtslander

Anonson

et al. 2017

Afr J Reprod Health

View full text Add to dashboard Cite

Breast cancer is the most common cancer in women particularly in developing countries like Nigeria, with high mortality, and economic costs. Worldwide, it is predicted that more than one million women are diagnosed with breast cancer, and more than 400,000 will die from the disease every year. A comparative integrative review of the literature from Nigeria and Canada showed that in Canada, there is positive association between wide spread education, early detection, the disease stage at diagnosis, and survival rates. In Nigeria, presentation with the advanced stage of the disease makes survival very low. The primary factors responsible for the late presentations are lack of awareness, misconceptions about breast cancer causes, and treatment outcomes. It is recommended that guidelines and policies about breast cancer early detection, care strategies, and ongoing management pathways be produced, disseminated, and adopted. The guidelines will assist practitioners and patients in making informed decisions and choices about the most appropriate health care for their specific clinical situations. The implementation of evidence-based guidelines will most likely help to improve care processes, the quality of clinical decisions and patient treatment outcome. RésuméLe cancer du sein est le cancer le plus commun chez les femmes, surtout dans les pays en développement comme le Nigeria, avec une mortalité élevée et des coûts économiques. Dans le monde entier, on prévoit que plus d'un million de femmes sont diagnostiquées avec un cancer du sein et plus de 400 000 mourront de la maladie chaque année. Un examen comparatif des documents venant du Nigéria et du Canada ont montré qu'au Canada, il existe une association positive entre l'éducation largement répandue, le dépistage précoce, le stade de la maladie au moment du diagnostic et les taux de survie. Au Nigéria, la présentation au stade avancé de la maladie rend la survie très faible. Les principaux facteurs responsables des présentations tardives sont le manque de sensibilisation, les idées fausses sur les causes du cancer du sein et les résultats du traitement. Il est recommandé de produire, de diffuser et d'adopter des lignes directrices et des politiques sur la détection précoce du cancer du sein, les stratégies de soins et les parcours de gestion en cours. Les lignes directrices aideront les praticiens et les patients à prendre des décisions et des choix éclairés sur les soins de santé les plus appropriés pour leurs situations cliniques spécifiques. La mise en oeuvre de lignes directrices fondées sur des données probantes contribuera vraisemblablement à améliorer les processus de soins, la qualité des décisions cliniques et les résultats du traitement de la patiente. (Afr J Reprod Health 2017; 21[2]: 18-25).

show abstract

Breast cancer management in middle-resource countries (MRCs): Consensus statement from the Breast Health Global Initiative

Cited by 56 publications

References 42 publications

Felt Needs for Rehabilitation After Breast Cancer Treatment in Mexico

Felt Needs for Rehabilitation After Breast Cancer Treatment in Mexico

Optimal Systemic Therapy for Early Breast Cancer in Women: A Clinical Practice Guideline

COMMENTARY: Promoting Early Detection of Breast Cancer and Care Strategies for Nigeria

Contact Info

Product

Resources

About